Fibrosis
Disease State Hub
Featured
08/25/2025
Kate Young
The FDA has announced the approval of the semaglutide injection to treat metabolic-associated steatohepatitis (MASH) in adults with moderate-to-advanced fibrosis following promising interim analysis data.
...
08/25/2025
08/22/2025
Anthony Calabro, MA
Metabolic dysfunction–associated steatohepatitis is becoming increasingly common in patients with type 2 diabetes and other metabolic risk factors. Test your knowledge of the key diagnostic features,...
08/22/2025
04/26/2023
Leigh Precopio
To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...
04/26/2023
Interactive Features
08/22/2025
Anthony Calabro, MA
Metabolic dysfunction–associated steatohepatitis is becoming increasingly common in patients with type 2 diabetes and other metabolic risk factors. Test your knowledge of the key diagnostic features,...
08/22/2025
01/03/2020
Think you know the main pathophysiologies of inflammation that lead to irreversible fibrosis? Take our quick quiz and find out!
01/03/2020
Clinical Insights
05/11/2018
Yelena Havryliuk, MD, FACOG, Assistant Professor of Obstetrics and Gynecology at Weill Cornell Medical College, describes the Acessa treatment for uterine fibroids and why it might be better than other...
05/11/2018
